CYP2D6 polymorphisms influence tamoxifen treatment outcomes in
Por um escritor misterioso
Descrição
Influence of CYP2D6 polymorphisms and other cytochrome P450 enzymes in
Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel? - ScienceDirect
CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial - ScienceDirect
CYP2D6 polymorphisms and their influence on risperidone treatment
Frontiers Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites
Medicina, Free Full-Text
CYP2D6: Unveiling the Mysteries of this Key Enzyme - FasterCapital
Genetic polymorphisms on the effectiveness or safety of breast cancer treatment: Clinical relevance and future perspectives - ScienceDirect
Does CYP2D6 Genotyping have a Role in Guiding Tamoxifen Therapy?
Clinical Relevance of CYP2D6 Genetics for Tamoxifen Response in Breast Cancer
PDF) Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen
de
por adulto (o preço varia de acordo com o tamanho do grupo)
